Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: The case of transferrin receptors

Blood Cells, Molecules, and Diseases

Volumn 41, Issue 2, 2008, Pages 203-209

  Chiotoglou, Ioanna ^a   Smilevska, Tatjana ^a,b   Samara, Maria ^a   Likousi, Sophia ^a   Belessi, Chrysoula ^c   Athanasiadou, Ioanna ^b   Stavroyianni, Niki ^b   Samara, Stavroula ^a   Laoutaris, Nikolaos ^c   Vamvakopoulos, Nikolaos ^a   Anagnostopoulos, Achilles ^b   Fassas, Athanasios ^b   Stamatopoulos, Kostas ^b   Kollia, Panagoula ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c GENERAL HOSPITAL OF NIKEA   (Greece)

Author keywords

B cell; CLL; Transcription; Transferrin receptor

Indexed keywords

CD71 ANTIGEN; CYCLOHEXIMIDE; DACTINOMYCIN; MESSENGER RNA; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

ANTIGENS, CD; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CYCLOHEXIMIDE; DACTINOMYCIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; UP-REGULATION;

EID: 48749109814     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.05.003     Document Type: Article

References (30)

1. Lash A., and Saleem A. Iron metabolism and its regulation. A review. Ann. Clin. Lab. Sci. 25 (1995) 20-30
2. Lieu P.T., Heiskala M., Peterson P.A., and Yang Y. The roles of iron in health and disease. Mol. Aspects Med. 22 (2001) 1-87
3. Brissot P., Troadec M.B., and Loreal O. The clinical relevance of new insights in iron transport and metabolism. Curr. Hematol. Rep. 3 (2004) 107-115
4. Kawabata H., Yang R., Hirama T., et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J. Biol. Chem. 274 (1999) 20826-20832
5. Kawabata H., Nakamaki T., Ikonomi P., et al. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. Blood 98 (2001) 2714-2719
6. Kawabata H., Germain R.S., Vuong P.T., et al. Transferrin receptor 2-a supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 275 (2000) 16618-16625
7. Richardson D.R., and Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331 (1997) 1-40
8. Seligman P.A., Kovar J., Schleicher R.B., and Gelfand E.W. Transferrin independent iron uptake supports B lymphocyte growth. Blood 78 (1991) 1526-1531
9. Ned R.M., Swat W., and Andrews N.C. Transferrin receptor 1 is differentially required in lymphocyte development. Blood 102 (2003) 3711-3718
10. Damle R.N., Ghiotto F., Valetto A., et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99 (2002) 4087-4093
11. Stevenson F.K., and Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103 (2004) 4389-4395
12. Chiorazzi N., Rai K.R., and Ferrarini M. Chronic lymphocytic leukemia. N. Engl. J. Med. 352 (2005) 804-815
13. Stamatopoulos K., Belessi C., Hadzidimitriou A., et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 106 (2005) 3575-3583
14. Lefranc M.P., Giudicelli V., Kaas Q., et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33 (2005) D593-D597
15. Giudicelli V., Chaume D., and Lefranc M.P. IMGT/V-QUEST, an integrated software for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 32 (2004) W435-440
16. Kollia P., Samara M., Stamatopoulos K., et al. Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia. Leuk. Res. 27 (2003) 1101-1103
17. Cheson B.D., Bennett J.M., Grever M., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87 (1996) 4990-4997
18. Damle R.N., Wasil T., Fais F., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840-1847
19. Hamblin T.J., Davis Z., Gardiner A., et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94 (1999) 1848-1854
20. Forconi F., Sahota S.S., Lauria F., and Stevenson F.K. Revisiting the definition of somatic mutational status in B-cell tumors: does 98% homology mean that a V(H)-gene is unmutated?. Leukemia 18 (2004) 882-883
21. Krober A., Seiler T., Benner A., et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100 (2002) 1410-1416
22. Ghia P., Guida G., Stella S., et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 101 (2003) 1262-1269
23. Osmond D.G. Population dynamics of bone marrow B lymphocytes. Immunol. Rev. 93 (1986) 103-124
24. Fitzsimmons D., and Haqman J. Regulation of gene expression at early stages of B-cell and T-cell differentiation. Curr. Opin. Immunol. 8 (1996) 166-174
25. Osmond D.G., Rolink A., and Melchers F. Murine B lymphopoiesis: towards a unified model. Immunol. Today 18 (1998) 65-68
26. Subramaniam V.N., Summerville L., and Wallace D.F. Molecular and cellular characterization of transferrin receptor 2. Cell Biochem. Biophys. 36 (2002) 235-239
27. Zent C.S., Zhan F., Schichman S.A., et al. The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype. Leuk. Res. 27 (2003) 765-774
28. Zhao H., Dugas N., Mathiot C., et al. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 92 (1998) 1031-1043
29. Kolb J.P., Roman V., Mentz F., et al. Contribution of nitric oxide to the apoptotic process in human B cell chronic lymphocytic leukaemia. Leuk. Lymphoma 40 (2001) 243-257
30. Tiscornia A.C., Cayota A., Landoni A.I., et al. Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions. Leukemia 18 (2004) 48-56